Calciprat may be available in the countries listed below.
Ingredient matches for Calciprat
Calcium Carbonate is reported as an ingredient of Calciprat in the following countries:
- France
- Tunisia
International Drug Name Search
Calciprat may be available in the countries listed below.
Calcium Carbonate is reported as an ingredient of Calciprat in the following countries:
International Drug Name Search
Calcit may be available in the countries listed below.
Calcitonin is reported as an ingredient of Calcit in the following countries:
Calcitriol is reported as an ingredient of Calcit in the following countries:
Calcium Carbonate is reported as an ingredient of Calcit in the following countries:
International Drug Name Search
Robenidine Hydrochloride
Type A Medicated Article
Coccidiostat
Robenidine hydrochloride 30 grams per pound (6.6%) in a carrier suitable for incorporation in feed.
For use in manufacturing medicated feeds only
Broiler chickens
As an aid in the prevention of coccidiosis caused by Eimeria mivati, E. brunetti, E. tenella, E. acervulina, E. maxima and E. necatrix in broiler chickens only.
Mix 1 pound of Robenz® Type A Medicated Article in one ton of feed to provide 30 grams per ton (0.0033%) robenidine hydrochloride concentration in feed.
Feed continuously as the sole ration. Do not use in feeds containing bentonite.
Type C feeds containing Robenz robenidine hydrochloride must be fed within 50 days from the date of manufacture.
Do not feed to chickens producing eggs for food.
Withdraw 5 days prior to slaughter.
Manufacture of Type B or C feeds from this product requires a Medicated Feed License Application approved by FDA.
Labels for feeds containing Robenz must contain appropriate indications, limitations and warnings as well as required feed ingredient information.
NADA 048-486, Approved by FDA
Marketed by
Alpharma Inc.
Bridgewater, New Jersey 08807
Net wt 50 LB (22.68 kg)
Trademarks registered by
Alpharma Inc.
Made in USA
740305 0905
Robenz®
ALPHARMA
Robenidine Hydrochloride
Type A Medicated Article
Coccidiostat
See back panel for use directions
Net wt 50 LB (22.68 kg)
ALPHARMA®
Robenz®
Robenz robenidine hydrochloride powder | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NADA | NADA048486 | 01/01/2009 |
Labeler - Alpharma Inc. Animal Health (070954094) |
Amlodipino Ranbaxy may be available in the countries listed below.
Amlodipine maleate (a derivative of Amlodipine) is reported as an ingredient of Amlodipino Ranbaxy in the following countries:
International Drug Name Search
Definition of Dietary Fiber Supplementation: Fiber is a substance found in plants. Dietary fiber -- the kind you eat -- is found in fruits, vegetables, and grains. It is an important part of a healthy diet.
The following drugs and medications are in some way related to, or used in the treatment of Dietary Fiber Supplementation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Cymine may be available in the countries listed below.
Dicycloverine hydrochloride (a derivative of Dicycloverine) is reported as an ingredient of Cymine in the following countries:
Simeticone is reported as an ingredient of Cymine in the following countries:
International Drug Name Search
Dantrium Capsules may cause serious, even fatal, liver problems, especially when used in larger amounts (800 mg/day or more). This side effect has occurred even in people who have taken Dantrium Capsules for a short period of time. The risk appears to be greater in women, people older than 35 years of age, people between their 3rd and 12th month of taking Dantrium Capsules, and people using other medicines at the same time. Lab tests, such as liver function tests, will be performed to check for side effects. Promptly notify your doctor if you have signs of liver problems, such as yellowing of the eyes or skin, dark urine, severe stomach or abdominal pain, or unusual fatigue.
Treating spasms (spasticity) caused by nerve disorders, such as stroke, cerebral palsy, spinal cord injury, or multiple sclerosis. It may be used prevent or reduce the risk of severe high body temperature (malignant hyperthermia) in certain patients before surgery or anesthesia. It may be used after an episode of severe high body temperature to prevent future episodes. It may also be used for other conditions as determined by your doctor.
Dantrium Capsules is a muscle relaxant. It works by interfering with the release of certain substances that are needed by the muscles for contraction, or by restoring a healthy level of calcium in the muscles, which helps to prevent or reduce severe high body temperature.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Dantrium Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Dantrium Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Dantrium Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Dantrium Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Dantrium Capsules.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; dizziness; drowsiness; general body discomfort; nausea; sensitivity to sunlight; unusual tiredness; vision changes; weakness.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blood in the urine; bloody or black, tarry stools; chest pain; coffee ground-like vomit; confusion; dark urine; depression; difficulty urinating; fast heartbeat; fever or chills; seizures; severe or persistent diarrhea; severe stomach or abdominal pain; shortness of breath; unusual tiredness; vomiting; yellowing of the skin or eyes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Dantrium side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from light, heat, and moisture. Do not store in the bathroom. Keep Dantrium Capsules out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Dantrium Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Alendroninezuur ActavisGroup may be available in the countries listed below.
Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendroninezuur ActavisGroup in the following countries:
International Drug Name Search